With a strong background in technology and healthcare, the fund manager has successfully executed over 30 investments primarily in North America and Europe. Emphasizing a data-driven approach, they have built a diverse portfolio that includes early to growth-stage companies. Their strategic style focuses on thematic investing, leading to notable exits in the biotechnology sector. This experience is complemented by a robust network, which enhances their ability to identify and capitalize on emerging market trends.